Bombesin and nutrients independently and additively regulate hormone release from GIP/Ins cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Li, Lin ^a   Wice, Burton M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Adenosine 5 monophosphate activated protein kinase related kinase; Enteric neurons; K cells; Nutrient sensing; Protein kinase C; Protein kinase D

Indexed keywords

ADENYLATE KINASE; ANTIBODY; BOMBESIN; GASTRIC INHIBITORY POLYPEPTIDE; GLYCERALDEHYDE; GROWTH HORMONE; HORMONE; INSULIN; PEPTIDE HORMONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE D; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL LINE; CELL STRAIN GIP; CELL STRAIN INS; CONTROLLED STUDY; ENDOCRINE CELL; ENZYME ACTIVITY; ENZYME REGULATION; GLUCOSE HOMEOSTASIS; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; INTESTINE CELL; KILLER CELL; LIPID DIET; NUTRIENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENYLATE KINASE; BOMBESIN; CARCINOGENS; CELLS, CULTURED; DRUG SYNERGISM; ENTEROENDOCRINE CELLS; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; INSULIN; PROTEIN HYDROLYSATES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 11144330068     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00346.2004     Document Type: Article

References (68)

1. Aiken KD, Kisslinger JA, and Roth KA. Immunohistochemical studies indicate multiple enteroendocrine cell differentiation pathways in the mouse proximal small intestine. Dev Dyn 201: 636-670, 1994.
2. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, and Small CJ. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279: 12005-12008, 2004.
3. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, and Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345, 2001.
4. Baba AS, Harper JM, and Buttery PJ. Effects of gastric inhibitory polypeptide, somatostatin and epidermal growth factor on lipogenesis in ovine adipose explants. Comp Biochem Physiol B Biochem Mol Biol 127: 173-182, 2000.
5. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, and Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
6. Beck B, Max JP, and Villaume C. Effects of somatostatin on the insulin-and gastric inhibitory polypeptide-stimulated fatty acid esterification in rat adipose tissue. Int J Obes 12: 41-47, 1988.
7. Blondel O, Bell GI, and Seino S. Inositol 1,4,5-trisphosphate receptors, secretory granules and secretion in endocrine and neuroendocrine cells. Trends Neurosci 18: 157-161, 1995.
8. Chini EN, Chini CC, Kato I, Takasawa S, and Okamoto H. CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues. Biochem J 362: 125-130, 2002.
9. Chiu T and Rozengurt E. PKD in intestinal epithelial cells: rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am J Physiol Cell Physiol 280: C929-C942, 2001.
10. Creutzfeldt W, Ebert R, Willms B, Frerichs H, and Brown JC. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia 14: 15-24, 1978.
11. Da Silva XG, Leclerc I, Varadi A, Tsuboi T, Moule SK, and Rutter GA. Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J 371: 761-774, 2003.
12. Drucker DJ. Glucagon-like peptides. Diabetes 47: 159-169, 1998.
13. Drucker DJ. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17: 161-171, 2003.
14. Ehert R, Frerichs H, and Creutzfeldt W. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest 9: 129-135, 1979.
15. Ebert R, Nauck M, and Creutzfeldt W. Effect of exogenous of endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Horm Metab Res 23: 517-521, 1991.
16. Eckel RH, Fujimoto WY, and Brunzell JD. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28: 1141-1142, 1979.
17. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, and Andres R. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes 33: 950-957, 1984
18. Fehmann H, Goke R, and Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr Rev 16: 390-410, 1995.
19. Hagar RE and Ehrlich BE. Regulation of the type III InsP3 receptor and its role in beta cell function. Cell Mol Life Sci 57: 1938-1949, 2000.
20. Hardie DG, Carling D, and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
21. Hardie DG, Scott JW, Pan DA, and Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003.
22. Hauner H, Glatting G, Kaminska D, and Pfeiffer EF. Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab 32: 282-288, 1988.
23. Hausser A, Link G, Bamberg L, Burzlaff A, Lutz S, Pfizenmaier K, and Johannes FJ. Structural requirements for localization and activation of protein kinase C mu (PKC mu) at the Golgi compartment. J Cell Biol 156: 65-74, 2002.
24. Iglesias T, Cabrera-Poch N, Mitchell MP, Naven TJ, Rozengurt E, and Schlavo G. Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J Biol Chem 275: 40048-40056, 2000.
25. Iglesias T and Rozengurt E. Protein kinase D activation by mutations within its pleckstrin homology domain. J Biol Chem 273: 410-416, 1998.
26. Iglesias T, Waldron RT, and Rozengurt E. Identification of in vivo phosphorylation sites required for protein kinase D activation. J Biol Chem 273: 27662-27667, 1998.
27. Islam MS. The ryanodine receptor calcium channel of β-cells: molecular regulation and physiological significance. Diabetes 51: 1299-1309, 2002.
28. Johannes FJ, Horn J, Link G, Haas E, Siemienski K, Wajant H, and Pfizenmaier K. Protein kinase Cμ downregulation of tumor-necrosis-factor- induced apoptosis correlates with enhanced expression of nuclear-factor- κB-dependent protective genes. Eur J Biochem 257: 47-54, 1998.
29. Kieffer TJ, Buchan AM, Barker H, Brown JC, and Pederson RA. Release of gastric inhibitory polypeptide from cultured canine endocrine cells. Am J Physiol Endocrinol Metab 267: E489-E496, 1994.
30. Knapper JM, Puddicombe SM, Morgan LM, Fletcher JM, and Marks V. Glucose dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide: effects on lipoprotein lipase activity (Abstract). Biochem Soc Trans 21: 135S, 1993.
31. Kotake K, Ozaki N, Mizuta M, Sekiya S, Inagaki N, and Seino S. Noc2, a putative zinc finger protein involved in exocytosis in endocrine cells. J Biol Chem 272: 29407-29410, 1997.
32. Li J, O'Connor KL, Hellmich MR, Greeley GHJ, Townsend CMJ, and Evers BM. The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase. J Biol Chem 279: 28466-28474, 2004.
33. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, and Alessi DR. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23: 833-843, 2004.
34. Matthews SA, Rozengurt E, and Cantrell D. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J Exp Med 191: 2075-2082, 2000.
35. Miller LJ. Gastrointestinal hormones and receptors. In: Textbook of Gastroenterology, edited by Yamada T, Alpers DH, Laine L, Owyang C, and Powell DW. Philadelphia, PA: Lippincott Williams & Wilkens, 1999, p. 35-66.
36. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, and Kahn BB. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: 569-574, 2004.
37. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, and Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8: 738-742, 2002.
38. Moore ED, Ring M, Scriven DR, Smith VC, Meloche RM, and Buchan AM. The role of protein kinase C isozymes in bombesin-stimulated gastrin release from human antral gastrin cells. J Biol Chem 274: 22493-22501, 1999.
39. Morgan LM, Hampton SM, Tredger JA, Cramb R, and Marks V. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet. Br J Nutr 59: 373-380, 1988.
40. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
41. Oben J, Morgan L, Fletcher J, and Marks V. Effect of the enteropancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130: 267-272, 1991.
42. Ramshur EB, Rull TR, and Wice BM. Novel insulin/GIP-producing cell lines provide unexpected insights into gut K-cell function in vivo. J Cell Physiol 192: 339-350, 2002.
43. Roth KA and Gordon JI. Spatial differentiation of the intestinal epithelium: analysis of enteroendocrine cells containing immunoreactive serotonin, secretin, and substance P in normal and transgenic mice. Proc Natl Acad Sci USA 87: 6408-6412, 1990.
44. Rutter GA. Nutrient-secretion coupling in the pancreatic islet β-cell: recent advances. Mol Aspects Med 22: 247-284, 2001.
45. Rutter GA, Da Silva XG, and Leclerc I. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16, 2003.
46. Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, and Barbara L. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. J Clin Endocrinol Metab 55: 329-336, 1982.
47. Sandler S and Eizirik DL. Culture of human pancreatic islet cells. In: Methods in Molecular Medicine: Human Cell Culture Protocols, edited by Jones GE. Totowa, NJ: Humana, 1994, p. 391-407.
48. Schmier WE. Gastrointestinal hormones. In: Textbook of Gastroenterology, edited by Yamada T. Philadelphia, PA: JB Lippincott, 1995, p. 25-71.
49. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
50. Sjolund K, Sanden G, Hakanson R, and Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85: 1120-1130, 1983.
51. Starich GH, Bar RS, and Mazzaferri EL. GIP increases insulin receptor affinity and cellular sensitivity in adipocytes. Am J Physiol Endocrinol Metab 249: E603-E607, 1985.
52. Stein SC, Woods A, Jones NA, Davison MD, and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443, 2000.
53. Sullivan JE, Brocklehurst KJ, Marley AE, Carey F, Carling D, and Beri RK. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett 353: 33-36, 1994.
54. Sykes S, Morgan LM, English J, and Marks V. Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. J Endocrinol 85: 201-207, 1980.
55. Taylor CW, Genazzani AA, and Morris SA. Expression of inositol trisphosphate receptors. Cell Calcium 26: 237-251, 1999.
56. Thrower EC, Hagar RE, and Ehrlich BE. Regulation of Ins(1,4,5)P3 receptor isoforms by endogenous modulators. Trends Pharmacol Sci 22: 580-586, 2001.
57. Tschop M, Smiley DL, and Heiman ML. Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
58. Waldron RT, Iglesias T, and Rozengurt E. Phosphorylation-dependent protein kinase D activation. Electrophoresis 20: 382-390, 1999.
59. Walsh JH. Gastrointestinal hormones. In: Physiology of the Gastrointestinal Tract, edited by Johnson LR. New York: Raven, 1994, p. 1-128.
60. ATP channel independent. Am J Physiol Endocrinol Metab 284: E988-E1000, 2003.
61. Wang SY, Liu J, Li L, and Wice BM. Individual sub-types of enteroendocrine cells in the mouse small intestine exhibit unique patterns of inositol 1,4,5-trisphosphate receptor expression. J Histochem Cytochem 52: 53-63, 2004.
62. Wasada T, McCorkle K, Harris V, Kawai K, Howard B, and Unger RH. Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs. J Clin Invest 68: 1106-1107, 1981.
63. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, and Carling D. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20: 6704-6711, 2000.
64. Yuan J, Bae D, Cantrell D, Nel AE, and Rozengurt E. Protein kinase D is a downstream target of protein kinase CO. Biochem Biophys Res Commun 291: 444-452, 2002.
65. Yuan J, Slice L, Walsh JH, and Rozengurt E. Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q). J Biol Chem 275: 2157-2164, 2000.
66. Yuan J, Slice LW, and Rozengurt E. Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. J Biol Chem 276: 38619-38627, 2001.
67. Zhukova E, Sinnett-Smith J, and Rozengurt E. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J Biol Chem 276: 40298-40305, 2001.
68. Zugaza JL, Waldron RT, Sinnett-Smith J, and Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J Biol Chem 272: 23952-23960, 1997.